- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ponesimod
Total 20 results
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
ActelionCompleted
-
ActelionCompleted
-
ActelionCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, Mexico, Poland, Portugal, Romania, Russian Federation, Serbia, S... and more
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
ActelionCompletedMultiple SclerosisUnited States, Spain, Hungary, Israel, Portugal, Germany, Russian Federation, Belarus, Poland, Serbia, Latvia, Turkey, Croatia, Canada, Czechia, Bulgaria, Bosnia and Herzegovina, Finland, France, Georgia, Greece, Italy, Lithuania, Mexico and more
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
ActelionCompleted
-
ActelionCompletedSafety and TolerabilityUnited Kingdom
-
ActelionCompleted
-
ActelionTerminatedMultiple SclerosisUnited States, Germany, Hungary, Poland, United Kingdom, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, France, Greece, Italy, Mexico, Portugal, Russian Federation, Spain, Switzerland
-
ActelionCompletedPsoriasisAustria, Belgium, Bulgaria, Czechia, Denmark, France, Hungary, Italy, Lithuania, Romania, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
ActelionCompletedPharmacokineticsSwitzerland
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
Beijing Tiantan HospitalRecruiting
-
IMPULS Endowment FundCompleted
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
The Cleveland ClinicUniversity of NottinghamRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
BiogenRecruitingMultiple SclerosisUnited States